Study of BHV-1400 in IgA Nephropathy

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

NCT03327857 ·Status: COMPLETED ·Phase: PHASE1

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

NCT01954979 ·Status: COMPLETED ·Phase: PHASE1

Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids

NCT03616184 ·Status: COMPLETED ·Phase: PHASE2

An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN

NCT06987864 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

NCT07290855 ·Status: COMPLETED ·Phase: PHASE4

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

NCT07046806 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD

NCT06843408 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy

NCT01762852 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Efficacy of Abatacept in IgG4-Related Disease

NCT03669861 ·Status: COMPLETED ·Phase: PHASE2

Rituximab for Anti-cytokine Autoantibody-Associated Diseases

NCT01842386 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

NCT06419205 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)

NCT01066598 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 in Adult Subjects With Hereditary Angioedema

NCT06846398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

NCT06541847 ·Status: RECRUITING ·Phase: PHASE2

Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

NCT06046248 ·Status: RECRUITING ·Phase: PHASE2

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

NCT00097695 ·Status: COMPLETED ·Phase: PHASE3

Study of Ravulizumab in Pediatric Participants With Primary IgAN

NCT07024563 ·Status: RECRUITING ·Phase: PHASE3

Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study

NCT01586858 ·Status: TERMINATED

Compassionate Use of Evinacumab

NCT06500598 ·Status: APPROVED_FOR_MARKETING

A Study of Belimumab in the Prevention of Kidney Transplant Rejection

NCT01536379 ·Status: COMPLETED ·Phase: PHASE2

Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease

NCT01147042 ·Status: TERMINATED ·Phase: PHASE4

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

NCT02959944 ·Status: COMPLETED ·Phase: PHASE3

HAT in Eye Complications of Behcet's Disease

NCT00001865 ·Status: COMPLETED ·Phase: PHASE2

Zanubrutinib in Patients With IgG4-Related Disease

NCT04602598 ·Status: COMPLETED ·Phase: PHASE2